articles

Shore Cap on Amryt at 18.5p - target price increased from 35p to 88p!

Tom Winnifrith Sunday 26 March 2017

 

Share this

Shore cap is House broker to Amryt Pharma (AMYT) so everything it writes cannot be said to be any way shape or form impartial. And since we own a shed load of the shares we are biased as hell too. Having said that this note is detailed and lifting the target price from 35p to 88p in light of recent news is pretty dramatic given that the shares were 18.5p on Friday when this "most excellent" research note came out.

Read the full article on ShareProphets | Comments

, , , , ,

About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Read next

Tom Winnifrith Bearcast: a Totally bogus balance sheet & results statement

Today it is Haile Selassie who gets de-statued. This confuses me. Then Nigel Wray gets confused as to the value of the FTSE 100 and of Apple. I share his confusion, can you help me. I discuss Burford (BUR) and then go to town on Totally (TLY) where the balance sheet is a joke and today’s results statement needs to be rewritten and re-issued. Finally I have just filmed the first main stage presentation for MineProphets on July 18. It is almpst an hour long and, I learned a lot from it, it really is most excellent. Book your seat HERE 

On ShareProphets
Thursday 9 July 2020
TomWinnifrith.com Copyright © . All rights reserved.
Created by Everywhen